Regeneron Pharmaceuticals, Inc.
TREATMENT OF FIBRODYSPLASIA OSSIFICANS PROGRESSIVA
Last updated:
Abstract:
Methods for treating Fibrodysplasia Ossificans Progressiva (FOP) are provided in which a subject having FOP is administered an effective regime of an antibody against Activin B, BMP9 or BMP10.
Status:
Application
Type:
Utility
Filling date:
14 Sep 2020
Issue date:
4 Mar 2021